Skip to main
TFX
TFX logo

Teleflex (TFX) Stock Forecast & Price Target

Teleflex (TFX) Analyst Ratings

Based on 24 analyst ratings
Buy
Strong Buy 17%
Buy 33%
Hold 46%
Sell 4%
Strong Sell 0%

Bulls say

Teleflex is poised for a positive outlook due to projected sales growth of at least 6% from a nearly $1 billion base, driven by the combined performance of its interventional business and anticipated revenue from acquired products. The company is expected to achieve moderate operating margin improvement and double-digit earnings growth, supported by strong revenue growth and cost reduction initiatives. Additionally, the firm’s growth potential is reinforced by a favorable product mix shift, ongoing new product launches, and the likelihood of accretive acquisitions, which collectively reinforce a positive earnings trajectory.

Bears say

Teleflex's recent financial performance has contributed to a negative outlook for its stock, highlighted by a significant share price decline of 22% following the release of its fourth-quarter 2024 results and disappointing 2025 guidance. The company has faced challenges such as missing consensus revenue expectations and projecting lower-than-expected growth rates, particularly in its UroLift product line and other key segments, leading to a revised 2025 earnings per share estimate of $14.17. Additionally, the planned acquisition of Biotronik's Vascular Intervention business for approximately $820 million has raised concerns about potential risks associated with larger acquisitions, including dilution of earnings per share.

Teleflex (TFX) has been analyzed by 24 analysts, with a consensus rating of Buy. 17% of analysts recommend a Strong Buy, 33% recommend Buy, 46% suggest Holding, 4% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Teleflex and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Teleflex (TFX) Forecast

Analysts have given Teleflex (TFX) a Buy based on their latest research and market trends.

According to 24 analysts, Teleflex (TFX) has a Buy consensus rating as of Aug 2, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $250.04, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $250.04, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Teleflex (TFX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.